UNOFFICIAL COPY 25 RS BR 2025
Page 1 of 2
XXXX 3/12/2025 7:15 PM Jacketed
A RESOLUTION encouraging the Kentucky Department for Public Health, in 1
conjunction with the Kentucky Office of Drug Control Policy, to issue a public statement 2
to increase awareness in the Commonwealth on the potential harm of consuming 7-3
hydroxymitragynine products. 4
WHEREAS, kratom contains two main chemical compounds, mitragynine and 7-5
hydroyxmitragynine, both of which bind to the same receptors in the brain as opioid 6
drugs such as codeine; and 7
WHEREAS, mitragynine is naturally present in kratom in much higher quantities 8
than 7-hydroxymitragynine; and 9
WHEREAS, 7-hydroxymitragynine is a terpenoid indole alkaloid that acts on the 10
brain’s opioid receptors; and 11
WHEREAS, according to the United States Food and Drug Administration, 7-12
hydroxymitragynine may produce classic opioid-related effects including sedation, 13
nausea and vomiting, physical dependence and withdrawals, and respiratory depression; 14
and 15
WHEREAS, 7-hydroxymitragynine is an addictive substance; and 16
WHEREAS, food chemists have developed techniques to synthesize 7-17
hydroxymitragynine from mitragynine allowing the artificial increase in the levels of 7-18
hydroxymitragynine in kratom products; and 19
WHEREAS, according to a study published in the Addiction Biology Journal, the 20
consumption of 7-hydroxymitragynine can lead to an increased utilization of other 21
opioids including morphine; and 22
WHEREAS, the analgesic properties of 7-hydroxymitragynine are 13 times greater 23
than morphine; and 24
WHEREAS, there are companies marketing products labeled as kratom that may 25
primarily contain the more potent synthetic product called 7-hydroxmitragynine; 26
NOW, THEREFORE, 27 UNOFFICIAL COPY 25 RS BR 2025
Page 2 of 2
XXXX 3/12/2025 7:15 PM Jacketed
Be it resolved by the House of Representatives of the General Assembly of the 1
Commonwealth of Kentucky: 2
Section 1. The members of the House of Representatives encourage the 3
Kentucky Department for Public Health, in conjunction with the Kentucky Office of 4
Drug Control Policy, to issue a public statement to increase awareness in the 5
Commonwealth on the potential harm of consuming 7-hydroxymitragynine products. 6
Section 2. The Clerk of the House of Representatives is directed to transmit a 7
copy of this Resolution to the Kentucky Department for Public Health, the Kentucky 8
Office of Drug Control Policy, and the Governor. 9